当前位置: X-MOL 学术Lancet Oncol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Labetuzumab govitecan in metastatic colorectal cancer
The Lancet Oncology ( IF 41.6 ) Pub Date : 2017-08-24 , DOI: 10.1016/s1470-2045(17)30664-2
Manjulika Das

Labetuzumab govitecan monotherapy might be safe and effective in patients with relapsed or refractory metastatic colorectal cancer previously treated with irinotecan-containing therapy.

中文翻译:

拉贝珠单抗地精子在转移性结直肠癌中的作用

Labetuzumab govitecan单一疗法对先前接受含伊立替康治疗的复发性或难治性转移性结直肠癌患者可能是安全有效的。
更新日期:2017-08-25
down
wechat
bug